LifeMD Inkomsten in het verleden
Verleden criteriumcontroles 0/6
LifeMD's earnings have been declining at an average annual rate of -10.8%, while the Healthcare Services industry saw earnings growing at 14% annually. Revenues have been growing at an average rate of 42.3% per year.
Belangrijke informatie
-10.8%
Groei van de winst
4.3%
Groei van de winst per aandeel
Healthcare Services Groei van de industrie | 1.7% |
Inkomstengroei | 42.3% |
Rendement op eigen vermogen | n/a |
Nettomarge | -14.9% |
Volgende winstupdate | 07 Nov 2024 |
Recente prestatie-updates uit het verleden
Recent updates
LifeMD: Are The Commons Too Cheap?
Sep 23LifeMD: Selling WorkSimpli Could Be A Catalyst
Sep 10It's Down 27% But LifeMD, Inc. (NASDAQ:LFMD) Could Be Riskier Than It Looks
Aug 16LifeMD: High Growth GLP-1 Telehealth Play At A Discount
Jul 31LifeMD: Pairing GLP-1 Agonists With Virtual Healthcare
Jun 11LifeMD: Moving Towards Profitability
May 22Is LifeMD (NASDAQ:LFMD) Using Debt Sensibly?
Apr 25Even With A 29% Surge, Cautious Investors Are Not Rewarding LifeMD, Inc.'s (NASDAQ:LFMD) Performance Completely
Mar 30LifeMD: Results And Guidance Point To Continued Strength In Weight Management Program
Mar 13LifeMD's 2024: Striking A Balance Between Rapid Expansion And Sustainability
Jan 22LifeMD: A GLP-1 Play With A Kicker
Jan 11Is LifeMD, Inc. (NASDAQ:LFMD) Potentially Undervalued?
Jan 05Take Care Before Jumping Onto LifeMD, Inc. (NASDAQ:LFMD) Even Though It's 34% Cheaper
Jan 05Does This Valuation Of LifeMD, Inc. (NASDAQ:LFMD) Imply Investors Are Overpaying?
Dec 03Investors Still Aren't Entirely Convinced By LifeMD, Inc.'s (NASDAQ:LFMD) Revenues Despite 38% Price Jump
Apr 17Analysts Are Betting On LifeMD, Inc. (NASDAQ:LFMD) With A Big Upgrade This Week
Nov 17LifeMD launches at-home screening kits for breast, colon cancers
Sep 14LifeMD Non-GAAP EPS of -$0.22 beats by $0.01, revenue of $30.5M misses by $1.45M
Aug 11LifeMD CEO Justin Schreiber - Disrupting Healthcare With Telemedicine
Jan 10Opbrengsten en kosten
Hoe LifeMD geld verdient en uitgeeft. Gebaseerd op laatst gerapporteerde winst, op LTM-basis.
Inkomsten en omzetgeschiedenis
Datum | Inkomsten | Inkomsten | G+A Uitgaven | R&D-uitgaven |
---|---|---|---|---|
30 Jun 24 | 178 | -27 | 163 | 8 |
31 Mar 24 | 164 | -26 | 149 | 7 |
31 Dec 23 | 153 | -24 | 137 | 6 |
30 Sep 23 | 136 | -32 | 127 | 5 |
30 Jun 23 | 129 | -33 | 123 | 4 |
31 Mar 23 | 123 | -39 | 125 | 4 |
31 Dec 22 | 119 | -49 | 131 | 3 |
30 Sep 22 | 118 | -55 | 136 | 2 |
30 Jun 22 | 112 | -61 | 137 | 2 |
31 Mar 22 | 104 | -64 | 134 | 1 |
31 Dec 21 | 93 | -62 | 125 | 1 |
30 Sep 21 | 78 | -75 | 131 | 1 |
30 Jun 21 | 64 | -85 | 129 | 1 |
31 Mar 21 | 51 | -73 | 106 | 1 |
31 Dec 20 | 37 | -63 | 85 | 0 |
30 Sep 20 | 28 | -32 | 48 | 0 |
30 Jun 20 | 20 | -9 | 21 | 0 |
31 Mar 20 | 14 | -5 | 14 | 0 |
31 Dec 19 | 12 | -3 | 12 | 0 |
30 Sep 19 | 11 | -3 | 10 | 0 |
30 Jun 19 | 10 | -3 | 10 | 0 |
31 Mar 19 | 9 | -3 | 9 | 0 |
31 Dec 18 | 8 | -2 | 8 | 0 |
30 Sep 18 | 6 | -2 | 7 | 0 |
30 Jun 18 | 6 | -2 | 6 | 0 |
31 Mar 18 | 5 | -1 | 5 | 0 |
31 Dec 17 | 4 | -1 | 4 | 0 |
30 Sep 17 | 5 | -2 | 4 | 0 |
30 Jun 17 | 3 | -1 | 5 | 0 |
31 Mar 17 | 4 | -2 | 5 | 0 |
31 Dec 16 | 5 | -1 | 4 | 0 |
30 Sep 16 | 5 | -1 | 4 | 0 |
30 Jun 16 | 4 | 0 | 2 | 0 |
31 Mar 16 | 3 | 0 | 1 | 0 |
31 Dec 15 | 1 | 0 | 1 | 0 |
30 Sep 15 | 1 | 0 | 1 | 0 |
30 Jun 15 | 1 | 0 | 1 | 0 |
31 Mar 15 | 1 | 0 | 1 | 0 |
31 Dec 14 | 1 | 0 | 1 | 0 |
30 Sep 14 | 1 | 0 | 1 | 0 |
30 Jun 14 | 1 | 0 | 1 | 0 |
31 Mar 14 | 1 | 0 | 1 | 0 |
31 Dec 13 | 1 | 0 | 1 | 0 |
Kwaliteitswinsten: LFMD is currently unprofitable.
Groeiende winstmarge: LFMD is currently unprofitable.
Analyse vrije kasstroom versus winst
Analyse van de winstgroei in het verleden
Winsttrend: LFMD is unprofitable, and losses have increased over the past 5 years at a rate of 10.8% per year.
Versnelling van de groei: Unable to compare LFMD's earnings growth over the past year to its 5-year average as it is currently unprofitable
Winst versus industrie: LFMD is unprofitable, making it difficult to compare its past year earnings growth to the Healthcare Services industry (35.1%).
Rendement op eigen vermogen
Hoge ROE: LFMD's liabilities exceed its assets, so it is difficult to calculate its Return on Equity.